SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-041299
Filing Date
2023-08-10
Accepted
2023-08-10 16:06:05
Documents
13
Period of Report
2023-08-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K eras-20230810.htm   iXBRL 8-K 50874
2 EX-99.1 eras-ex99_1.htm EX-99.1 209250
  Complete submission text file 0000950170-23-041299.txt   392675

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eras-20230810_lab.xml EX-101.LAB 13904
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eras-20230810_pre.xml EX-101.PRE 10218
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eras-20230810.xsd EX-101.SCH 2451
7 EXTRACTED XBRL INSTANCE DOCUMENT eras-20230810_htm.xml XML 4879
Mailing Address 10835 ROAD TO THE CURE, SUITE 140 SAN DIEGO CA 92121
Business Address 10835 ROAD TO THE CURE, SUITE 140 SAN DIEGO CA 92121 (858) 465-6511
Erasca, Inc. (Filer) CIK: 0001761918 (see all company filings)

IRS No.: 831217027 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40602 | Film No.: 231159298
SIC: 2834 Pharmaceutical Preparations